BAYER HEALTHCARE PHARMACEUTICALS INC
Entity uei:V1EVGCK7XES8 · UEI V1EVGCK7XES8
Obligations by fiscal year
Awards (5)
| 36C25626N0126↗ RADIUM FOR CANCER TREATMENT | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Oct 1, 2025 – Aug 20, 2026 | $215K | — | 0 |
| 36C26226F0163↗ XOFIGO - RADIUM RA 223DICHLORIDE INJ | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Apr 1, 2026 – Mar 31, 2027 | $181K | — | 0 |
| 36C25024F0075↗ EMERGENCY RADIUM 223 XOFIGO THERAPY | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Oct 16, 2023 – Sep 30, 2024 | $111K | — | 0 |
| 36C26126N0199↗ ORDER FOR XOFIGO RA223 DICHLORIDE INJECTION | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Nov 6, 2025 – Jan 5, 2026 | $102K | — | 0 |
| 36C24824N0873↗ EMERGENCY RADIUM RA 223 DICHLORIDE - XOFIGO | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Jun 20, 2024 – Jun 20, 2024 | $101K | — | 0 |
Observed spellings (1)
Raw recipient names from source records that resolved to this entity.
- BAYER HEALTHCARE PHARMACEUTICALS INC
V1EVGCK7XES8· seen 15×